AIO-LQ-0110
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
II
interventionell
National
Erythromycin (Aknemycin®), Doxycyclin (Doxycyclin STADA®)
Status: Studie beendet
Zeitraum
2011
2016
Zentren
17
Keine Zentren gesucht
Patienten
88
86
19.04.2022
Identifier
AIO-LQ-0110
AIO-LQ-0110
2010-022938-85
Kontakt
Leitung
Dr. Melanie Kripp
Ansprechpartner*in
AIO-Studien-gGmbH
Telefon +49 30 322932931
E-Mail info@aio-studien-ggmbh.de